News
IGC
--
0.00%
--
India Globalization Capital reports FY results
India Globalization Capital (IGC): FY GAAP EPS of -$0.21.Revenue of $0.9M (-77.9% Y/Y)Shares +4.35% PM.Press Release
Seekingalpha · 3d ago
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits
/PRNewswire/ -- Cannabidiol (CBD) extract is a product that's derived from cannabis. It's a type of cannabinoid, which are the chemicals naturally found in marijuana plants. Even though it comes from marijuana plants, CBD doesn't create a "high" effect or ...
PR Newswire - PRF · 06/10 12:30
WKHS, BNGO, CLOV and SFIX among notable premarket gainers
Clover Health Investments (CLOV) +37%.Aytu Biopharma (AYTU) +20%.NextDecade Corporation (NEXT) +20% after Morgan Stanley upgrades on Rio Grande LNG outlook.Cyclerion Therapeutics (CYCN) +16%.The Wendy's (WEN) +16%.Stitch Fix (SFIX) +14% on Q3 results.PDS B...
Seekingalpha · 06/08 12:26
IGC progresses into Cohort 3 of early-stage study of IGC-AD1 in Alzheimer’s disease
India Globalization Capital (IGC) has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol ((THC))-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering
Seekingalpha · 06/08 09:42
BRIEF-IGC Completes Cohort 2 Of Its Phase 1 THC-Based Clinical Trial On Alzheimer's Patients
reuters.com · 06/08 03:28
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients
IGC Completes Cohort 2 of its Phase 1 Tetrahydrocannabinol ("THC")-Based Investigational New Drug Clinical Trial on Alzheimer’s Patients.
Business Wire · 06/08 03:26
FuelCell Energy and Euroseas among industrial gainers; Fuel Teck leads the losers
Gainers: Euroseas (ESEA) +25%. StarTek (SRT) +19%. India Globalization Capital (IGC) +18%. FuelCell Energy (FCEL) +15%. PureCycle Technologies (PCT) +15%.Losers: Fuel Teck (FTEK) -13%. ShiftPixy (PIXY) -12%. Custom Truck One Source (CTOS) -12%. Aenza (AENZ...
Seekingalpha · 06/07 17:03
Virgin Galactic and Veritiv among industrial gainers; Castor Maritime leads the losers
Gainers: Veritiv (VRTV) +17%. Virgin Galactic (SPCE) +17%. Quest Resource Holding (QRHC) +12%. Mayville Engineering (MEC) +13%. Diana Shipping (DSX) +8%.Losers: Castor Maritime (CTRM) -14%. Navios Maritime Partners (NMM) -11%. Euro Tech (CLWT) -9%. Sino-Gl...
Seekingalpha · 05/24 17:03
SPCE, GTX, STEM and FTCI among premarket gainers
Creative Realities (CREX) +34%.Virgin Galactic Holdings (SPCE) +19% after successful weekend space flight.Strongbridge Biopharma (SBBP) +15% after being acquired by Xeris Pharma.Jiuzi Holdings (JZXN) +9%.Aptorum Group Limited (APM) +9% on positive interim ...
Seekingalpha · 05/24 12:18
UPDATE: Cannabis Stocks Move Higher Amid Update On Timeline For Revised Federal Marijuana Legislation In To House, As Early As Next Week
https://www.marijuanamoment.net/key-chairman-plans-to-file-revised-federal-marijuana-legalization-bill-in-house-as-early-as-next-week/   A May 12 article did not include the
/   A May 12 article did not include the · 05/21 15:03
India Globalization Capital Shares Rise 10% After Trial Cohort Finishes
By Chris Wack India Globalization Capital Inc. shares were up 10% to $1.37 Friday after the company said it has completed cohort 1 of its Phase 1 clinical...
marketwatch.com · 05/14 17:54
PLUG, RIOT, BNGO and MARA among notable premarket gainers
Fisker (FSR) +15% after announcing an agreement with Foxconn to produce a new vehicle.Net Element (NETE) +15%.Hallmark Financial Services (HALL) +14% on Q1 results.LifeMD (LFMD) +15% on Q1 results.Aeva Technologies (AEVA) +14% on Q1 results.Elys Game
Seekingalpha · 05/14 12:21
India Globalization Capital Completes Cohort 1 of Alzheimer's Treatment Trial
By Chris Wack India Globalization Capital Inc. said it has completed Cohort 1 of its Phase 1 clinical trial testing its tetrahydrocannabinol-based...
marketwatch.com · 05/14 10:34
BRIEF-India Globalization Capital Completes Cohort 1 Of Phase 1 THC-Based Clinical Trial
reuters.com · 05/14 10:20
India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) announces today that it has completed Cohort 1 of its Phase 1 clinical trial testing the IGC's tetrahydrocannabinol ("THC")-based formulation, IGC-AD1, intended to alleviate th...
BusinessWire · 05/14 10:01
India Globalization Capital Makes Progress on Formulation Designed to Alleviate Symptoms of Alzheimer's Disease
MT Newswires · 05/14 07:09
India Globalization Capital Stock Is Believed To Be Significantly Overvalued
GuruFocus News · 04/29 15:12
RIOT, MVIS, MSRT and FOLD among premarket gainers
Galectin Therapeutics (GALT) +27% as its belapectin + Keytruda enhances tumor response in melanoma, head/neck cancer.Bit Digital (BTBT) +17%.UTStarcom Holdings (UTSI) +14%.Greenwich LifeSciences (GLSI) +15% after update on GP2 phase III clinical
Seekingalpha · 04/14 12:22
SuperCom leads industrial gainers; Raven Industries and Construction Partners among the losers
Gainers: SuperCom (SPCB) +46%. Euroseas (ESEA) +22%. India Globalization Capital (IGC) +14%. Flux Power (FLUX) +11%. Alta Equipment (ALTG) +11%.Losers: Raven Industries (RAVN) -9%. SGOCO Group (SGOC) -8%. Manitex International (MNTX) -8%. Construction
Seekingalpha · 03/19 17:03
BZ NOTE Following Monday Doc From DC Mayor Showing Funds Were Expended For Cannabis Legalization Bill (See Body Of This Headline For The Context)
A member of Benzinga's cannabis newsdesk responded to trader circulation of the doc and the resulting price action in cannabis stocks: ""A federal agency says a spending rider that prevents DC from
Benzinga · 03/09 13:56
Webull provides a variety of real-time IGC stock news. You can receive the latest news about INDIA GLBL CPTL through multiple platforms. This information may help you make smarter investment decisions.
About IGC
India Globalization Capital, Inc. develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. The Company also builds farming facilities for leasing. In Malaysia, the Company develops and manages residential and commercial real estate. In India, it leases heavy equipment. It is also focused on developing, testing and patenting phytocannabinoid-based pharmaceutical therapies and becoming a specialty pharmaceutical provider of phytocannabinoid-based pharmaceutical and nutraceutical products. It is developing a product portfolio of phytocannabinoid-based therapies for indications, including neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis. In Malaysia, the Company’s subsidiary, Cabaran Ultima Sdn. Bhd., is focused on building a five-star hotel, Genting highlands.